Insider Transactions in Q2 2024 at Aerovate Therapeutics, Inc. (AVTE)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2024
|
Ra Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect |
928,110
+10.52%
|
$928,110
$1.67 P/Share
|
|
Jun 14
2024
|
Marinus Verwijs CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,600
-100.0%
|
$265,000
$25.0 P/Share
|
|
Jun 14
2024
|
Marinus Verwijs CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,600
+50.0%
|
$148,400
$14.59 P/Share
|
|
Jun 14
2024
|
George A Eldridge |
SELL
Open market or private sale
|
Direct |
15,000
-74.92%
|
$375,000
$25.03 P/Share
|
|
Jun 14
2024
|
George A Eldridge |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+42.83%
|
$30,000
$2.14 P/Share
|
|
Jun 13
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,000
-51.72%
|
$144,000
$24.5 P/Share
|
|
Jun 13
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+34.09%
|
$12,000
$2.14 P/Share
|
|
May 17
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,000
-21.14%
|
$84,000
$21.47 P/Share
|
|
May 17
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+29.41%
|
$8,000
$2.14 P/Share
|
|
May 16
2024
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-93.54%
|
$210,000
$21.72 P/Share
|
|
May 16
2024
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$20,000
$2.14 P/Share
|
|
May 02
2024
|
Marinus Verwijs CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,981
-100.0%
|
$41,601
$21.02 P/Share
|
|
May 01
2024
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
11,357
-96.78%
|
$227,140
$20.37 P/Share
|
|
May 01
2024
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$20,000
$2.14 P/Share
|
|
Apr 17
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,000
-29.8%
|
$88,000
$22.82 P/Share
|
|
Apr 17
2024
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+35.55%
|
$4,000
$1.74 P/Share
|
|
Apr 17
2024
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
6,853
-34.69%
|
$157,619
$23.15 P/Share
|
|
Apr 17
2024
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
6,853
+45.7%
|
$13,706
$2.14 P/Share
|
|
Apr 16
2024
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-72.46%
|
$240,000
$24.67 P/Share
|
|
Apr 16
2024
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$20,000
$2.14 P/Share
|
|
Apr 10
2024
|
George A Eldridge |
SELL
Open market or private sale
|
Direct |
7,500
-49.68%
|
$202,500
$27.17 P/Share
|
|
Apr 10
2024
|
George A Eldridge |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+44.22%
|
$15,000
$2.14 P/Share
|
|
Apr 09
2024
|
David S. Grayzel |
SELL
Open market or private sale
|
Indirect |
11,882
-45.03%
|
$332,696
$28.15 P/Share
|
|
Apr 01
2024
|
George A Eldridge |
SELL
Open market or private sale
|
Direct |
12,495
-86.44%
|
$387,345
$31.23 P/Share
|
|
Apr 01
2024
|
George A Eldridge |
BUY
Exercise of conversion of derivative security
|
Direct |
12,495
+46.36%
|
$24,990
$2.14 P/Share
|
|
Apr 01
2024
|
Marinus Verwijs CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,300
-85.81%
|
$153,700
$29.44 P/Share
|
|
Apr 01
2024
|
Marinus Verwijs CHIEF TECHNICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,300
+50.0%
|
$74,200
$14.59 P/Share
|
|
Apr 01
2024
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
3,325
-72.03%
|
$103,075
$31.97 P/Share
|
|
Apr 01
2024
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
3,325
+41.87%
|
$33,250
$10.61 P/Share
|
|
Apr 01
2024
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-62.25%
|
$300,000
$30.46 P/Share
|
|
Apr 01
2024
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$20,000
$2.14 P/Share
|